Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director CC transcript
|
ORTHOVITA INC (VITA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/05/2011 |
8-K
| Form 8-K - Current report |
03/14/2011 |
8-K
| Form 8-K - Current report |
11/03/2010 |
8-K
| Form 8-K - Current report |
08/02/2010 |
8-K
| Form 8-K - Current report |
03/10/2010 |
8-K
| Quarterly results |
11/05/2009 |
8-K
| Form 8-K - Current report |
08/06/2009 |
8-K
| Form 8-K - Current report |
05/07/2009 |
8-K
| Form 8-K -- Current report |
03/12/2009 |
8-K
| Quarterly results |
11/04/2008 |
8-K
| Quarterly results |
08/07/2008 |
8-K
| Quarterly results |
05/08/2008 |
8-K
| Quarterly results |
03/13/2008 |
8-K
| Quarterly results |
11/06/2007 |
8-K
| Quarterly results |
08/07/2007 |
8-K
| Quarterly results |
05/07/2007 |
8-K
| Quarterly results |
10/31/2006 |
8-K
| Quarterly results |
08/04/2006 |
8-K
| Quarterly results |
05/02/2006 |
8-K
| Quarterly results
Docs:
|
"ORTHOVITA, INC. AND SUBSIDIARIES Summary Financial Information Statements of Operations Data: Three Months Ended March 31, 2006 % of Product Sales 2005 % of Product Sales PRODUCT SALES $ 10,816,956 100 % $ 7,885,737 100 % COST OF SALES 3,511,175 32 % 2,496,883 32 % GROSS PROFIT 7,305,781 68 % 5,388,854 68 % OPERATING EXPENSES: General & administrative expenses 2,105,780 20 % 1,716,317 22 % Selling & marketing expenses 6,947,027 64 % 5,086,394 65 % Research & development expenses 2,105,203 19 % 1,379,425 17 % Total operating expenses 11,158,010 103 % 8,182,136 104 % OPERATING LOSS % % Other expense, net % % NET LOSS $ % $ % NET LOSS PER COMMON SHARE, BASIC AND DILUTED $ $ SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE 52,321,863 47,837,038 Summary Financial Information..." |
|
02/28/2006 |
8-K
| Quarterly results
Docs:
|
"ORTHOVITA, INC. AND SUBSIDIARIES Summary Financial Information Three Months Ended December 31, Twelve Months Ended December 31, 2005 2004 2005 2004 Statements of Operations Data: PRODUCT SALES $ 9,971,231 100 % $ 7,092,947 100 % $ 34,679,298 100 % $ 24,661,382 100 % COST OF SALES 3,653,577 37 % 2,540,192 36 % 12,651,578 36 % 7,758,892 31 % GROSS PROFIT 6,317,654 63 % 4,552,755 64 % 22,027,720 64 % 16,902,490 69 % OPERATING EXPENSES: General & administrative expenses 1,631,673 16 % 1,638,450 23 % 6,661,628 19 % 5,595,049 23 % Selling & marketing expenses 5,998,630 60 % 5,253,849 74 % 21,126,567 61 % 18,187,113 74 % Research & development expenses 1,843,966 19 % 1,432,253 20 % 7,166,887 21 % 5,657,349 23 % Total operating expenses 9,474,269 95 % 8,324,552 117 % 34,955,082 101 % 29,439,511 12..." |
|
|
|